Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease
- PMID: 366589
Dantrolene sodium in the treatment of spasticity in chronic spinal cord disease
Similar articles
-
[Attenuating effect of a new pharmacological agent (Dantrolene sodium) on spasticity].Union Med Can. 1973 May;102(5):1087-92. Union Med Can. 1973. PMID: 4576244 Clinical Trial. French. No abstract available.
-
A comparison of dantrolene sodium and diazepam in the treatment of spasticity.Paraplegia. 1974 Nov;12(3):170-4. doi: 10.1038/sc.1974.27. Paraplegia. 1974. PMID: 4616209 Clinical Trial. No abstract available.
-
[Dantrolene in the treatment of spasticity].Harefuah. 1978 Jul 2;95(1):10-1. Harefuah. 1978. PMID: 359424 Clinical Trial. Hebrew. No abstract available.
-
Dantrolene sodium: a review of its pharmacological properties and therapeutic efficacy in spasticity.Drugs. 1977 Jan;13(1):3-23. doi: 10.2165/00003495-197713010-00002. Drugs. 1977. PMID: 318989 Review.
-
[Intrathecal baclofen for severe spasticity].Brain Nerve. 2008 Dec;60(12):1415-20. Brain Nerve. 2008. PMID: 19110752 Review. Japanese.
Cited by
-
Pharmacological interventions for spasticity following spinal cord injury.Cochrane Database Syst Rev. 2000;2000(2):CD001131. doi: 10.1002/14651858.CD001131. Cochrane Database Syst Rev. 2000. PMID: 10796750 Free PMC article.
-
Anti-spasticity agents for multiple sclerosis.Cochrane Database Syst Rev. 2000;2003(4):CD001332. doi: 10.1002/14651858.CD001332. Cochrane Database Syst Rev. 2000. Update in: Cochrane Database Syst Rev. 2001;(4):CD001332. doi: 10.1002/14651858.CD001332. PMID: 11034714 Free PMC article. Updated.
-
Latest approaches for the treatment of spasticity and autonomic dysreflexia in chronic spinal cord injury.Neurotherapeutics. 2011 Apr;8(2):274-82. doi: 10.1007/s13311-011-0025-5. Neurotherapeutics. 2011. PMID: 21384222 Free PMC article. Review.
-
Dantrolene.Can Anaesth Soc J. 1984 Jan;31(1):61-75. doi: 10.1007/BF03011484. Can Anaesth Soc J. 1984. PMID: 6362802 Review. No abstract available.